Skip to main content
. 2018 Jan 25;37(15):1991–2007. doi: 10.1038/s41388-017-0081-3

Fig. 5.

Fig. 5

Contribution of candidate oncogenic microRNAs to FP-RMS. a qRT-PCR microRNA expression in Rh41 cells 3 days after transfection with indicated negative control (NC) or antimiR. b Cell Titer Glo cell viability assay in Rh41 cells as in (a). c qRT-PCR in Rh30 cells transfected with antimiR-486-5p or NC 3 days after transfection. d Cell Titer Glo cell viability and e Caspase 3/7 Glo apoptosis assay in Rh30 cells as in (c). *P < 0.05, **P < 0.01, ***P < 0.001 for antimiRs vs NC